Log in

NASDAQ:MGLNMagellan Health Stock Price, Forecast & News

$70.32
+0.73 (+1.05 %)
(As of 07/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$69.60
Now: $70.32
$72.35
50-Day Range
$67.54
MA: $71.87
$76.92
52-Week Range
$30.60
Now: $70.32
$81.04
Volume69,800 shs
Average Volume149,290 shs
Market Capitalization$1.76 billion
P/E Ratio23.52
Dividend YieldN/A
Beta1.22
Magellan Health, Inc. provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans (EAP); and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. It offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions. The company provides services to health plans and other managed care organizations, employers, labor unions, various military and governmental agencies, and third party administrators. Magellan Health, Inc. was founded in 1969 and is headquartered in Scottsdale, Arizona.
Read More
Magellan Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.73 out of 5 stars


Industry, Sector and Symbol

Industry Hospitals
Sub-IndustryManaged Health Care
SectorMedical
Current SymbolNASDAQ:MGLN
CUSIP55907920
Phone602-572-6050

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.16 billion
Cash Flow$9.20 per share
Book Value$57.13 per share

Profitability

Net Income$55.90 million

Miscellaneous

Employees10,100
Market Cap$1.76 billion
Next Earnings Date8/4/2020 (Estimated)
OptionableOptionable

Receive MGLN News and Ratings via Email

Sign-up to receive the latest news and ratings for MGLN and its competitors with MarketBeat's FREE daily newsletter.

Magellan Health (NASDAQ:MGLN) Frequently Asked Questions

How has Magellan Health's stock been impacted by COVID-19 (Coronavirus)?

Magellan Health's stock was trading at $53.88 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, MGLN stock has increased by 30.5% and is now trading at $70.32. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Magellan Health?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Magellan Health in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Magellan Health.

When is Magellan Health's next earnings date?

Magellan Health is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Magellan Health.

How were Magellan Health's earnings last quarter?

Magellan Health Inc (NASDAQ:MGLN) announced its quarterly earnings results on Monday, May, 11th. The company reported $1.15 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.72 by $0.43. The company had revenue of $1.79 billion for the quarter, compared to analyst estimates of $1.78 billion. Magellan Health had a net margin of 1.02% and a return on equity of 8.02%. The business's revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.40 EPS. View Magellan Health's earnings history.

What price target have analysts set for MGLN?

1 brokerages have issued 1 year price objectives for Magellan Health's shares. Their forecasts range from $67.00 to $67.00. On average, they anticipate Magellan Health's share price to reach $67.00 in the next year. This suggests that the stock has a possible downside of 4.7%. View analysts' price targets for Magellan Health.

Has Magellan Health been receiving favorable news coverage?

Headlines about MGLN stock have been trending somewhat positive this week, according to InfoTrie Sentiment. The research group scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Magellan Health earned a news impact score of 1.9 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days. View the latest news about Magellan Health.

Who are some of Magellan Health's key competitors?

What other stocks do shareholders of Magellan Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Magellan Health investors own include Energy Transfer LP Unit (ET), General Motors (GM), Netflix (NFLX), Boeing (BA), Ford Motor (F), NVIDIA (NVDA), UnitedHealth Group (UNH), Broadcom (AVGO), ConocoPhillips (COP) and Enbridge (ENB).

Who are Magellan Health's key executives?

Magellan Health's management team includes the following people:
  • Mr. Barry Morgan Smith, Chairman, CEO & CEO of Magellan Healthcare (Age 65)
  • Mr. Jonathan Neal Rubin, Chief Financial Officer (Age 55)
  • Mr. Daniel Norman Gregoire, Gen. Counsel & Sec. (Age 63)
  • Mr. Mostafa M. Kamal, Chief Exec. Officer of Magellan Rx Management (Age 38)
  • Ms. Renie Shapiro Silver, SVP - Corp. Fin.

What is Magellan Health's stock symbol?

Magellan Health trades on the NASDAQ under the ticker symbol "MGLN."

Who are Magellan Health's major shareholders?

Magellan Health's stock is owned by many different retail and institutional investors. Top institutional investors include Envestnet Asset Management Inc. (0.03%) and Everence Capital Management Inc. (0.02%). Company insiders that own Magellan Health stock include James E Murray and Jeffrey N West. View institutional ownership trends for Magellan Health.

Which institutional investors are buying Magellan Health stock?

MGLN stock was purchased by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., and Everence Capital Management Inc.. View insider buying and selling activity for Magellan Health.

How do I buy shares of Magellan Health?

Shares of MGLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Magellan Health's stock price today?

One share of MGLN stock can currently be purchased for approximately $70.32.

How big of a company is Magellan Health?

Magellan Health has a market capitalization of $1.76 billion and generates $7.16 billion in revenue each year. The company earns $55.90 million in net income (profit) each year or $3.73 on an earnings per share basis. Magellan Health employs 10,100 workers across the globe.

What is Magellan Health's official website?

The official website for Magellan Health is www.magellanhealth.com.

How can I contact Magellan Health?

Magellan Health's mailing address is 4800 SCOTTSDALE ROAD, SCOTTSDALE AZ, 85251. The company can be reached via phone at 602-572-6050 or via email at [email protected]

This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.